🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

UPDATE 2-Ackman says Pershing Square down for the year after markets drop

Published 2015-08-26, 07:00 p/m
© Reuters.  UPDATE 2-Ackman says Pershing Square down for the year after markets drop
US500
-
APD
-
AGN_pa
-
BHC
-
HLF
-
MDLZ
-
ZTS
-

(Adds details on investments)
By Svea Herbst-Bayliss
BOSTON, Aug 26 (Reuters) - Billionaire investor William
Ackman, one of last year's best performing hedge fund managers,
is now losing money after the recent market plunge wiped out a
double-digit gain.
The shift of fortunes shows how much tumbling markets,
sparked by sharp declines in Chinese stock prices, have
hurt the world's most prominent investors.
"At the date of this report, the year to date investment
performance has been erased, and the Company is at a loss
position for the year," Ackman's Pershing Square Capital
Management said in its interim financial statement released to
investors on Wednesday afternoon.
Only three weeks ago the New York-based manager had told
clients, including state pension funds in Massachusetts and New
Jersey, that the fund was up 10.1 percent for the year through
the end of July.
Ackman is one of the first major money managers to tell his
investors how the market turmoil has hit his firm, but he did
not say how much money the fund has lost this year.
He and other hedge fund managers are expected to release
monthly performance numbers next week.
Despite the sharp market moves, Pershing Square, which holds
only a small number of investments at a time, has "made no
meaningful recent changes to (our) current portfolio holdings,"
Ackman said in the financial statement.
Lower commodity prices or economic weakness in China are
unlikely to have a "material impact on the intrinsic value of
the portfolio," Ackman added.
Instead, he expects demand for cookies, industrial gases,
specialty pharmaceutical products, and animal health products
made by companies in his portfolio such as Mondelez
International Inc MDLZ.O , Air Products and Chemicals Inc (NYSE:APD)
APD.N , Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO and
Zoetis Inc (NYSE:ZTS) ZTS.N to remain "robust over the long-term."
In the first six months of the year, Allergan (NYSE:AGN_pa), Valeant,
Nomad Foods and Mondelez were the fund's biggest winners.
Meanwhile Herbalife (NYSE:HLF) Ltd HLF.N , which he has made a $1 billion
short bet against, cost the fund 3.7 percent in returns.
Due to recent strong returns, the fund's size had swelled to
roughly $20 billion, but that is set to shrink in light of the
latest drop. Ackman did not put a number on that decline.
Last year Pershing Square gained 40.4 percent in value while
the Standard & Poor's 500 index rose 13.7 percent.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.